{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:12:40Z","timestamp":1770999160100,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T00:00:00Z","timestamp":1420675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.reprotox.2014.12.007","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T18:42:15Z","timestamp":1419014535000},"page":"18-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Efinaconazole: Developmental and reproductive toxicity potential of a novel antifungal azole"],"prefix":"10.1016","volume":"52","author":[{"given":"M.","family":"Glynn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Minowa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Sanada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Nejishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Matsuuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Mutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reprotox.2014.12.007_bib0005","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1128\/AAC.02063-12","article-title":"Mechanism of action of efinaconazole, a novel triazole antifungal agent","volume":"57","author":"Tatsumi","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.reprotox.2014.12.007_bib0010","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.bbagen.2006.09.016","article-title":"Mammalian cytochromes P450 \u2013 importance of tissue specificity","volume":"1770","author":"Seliskar","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.reprotox.2014.12.007_bib0015","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s001090050286","article-title":"Meiosis-activating sterols: background, discovery, and possible use","volume":"76","author":"Byskov","year":"1998","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.reprotox.2014.12.007_bib0020","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/CMR.12.1.40","article-title":"Current and emerging azole antifungal agents","volume":"12","author":"Sheehan","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.reprotox.2014.12.007_bib0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.toxlet.2010.07.005","article-title":"Are azole fungicides a teratogenic risk for human conceptus?","volume":"198","author":"Giavini","year":"2010","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.reprotox.2014.12.007_bib0030","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1289\/ehp.5785","article-title":"Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14 alpha-demethylase and aromatase","volume":"111","author":"Zarn","year":"2003","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.reprotox.2014.12.007_bib0035","doi-asserted-by":"crossref","first-page":"29086","DOI":"10.1074\/jbc.M111.253245","article-title":"Mouse knockout of the cholesterogenic cytochrome P450 lanosterol 14alpha-demethylase (Cyp51) resembles Antley\u2013Bixler syndrome","volume":"286","author":"Keber","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.reprotox.2014.12.007_bib0040","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/clinids\/22.2.336","article-title":"Fluconazole-induced congenital anomalies in three infants","volume":"22","author":"Pursley","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.reprotox.2014.12.007_bib0045","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/00006454-199211120-00017","article-title":"Congenital malformations in an infant born to a woman treated with fluconazole","volume":"11","author":"Lee","year":"1992","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.reprotox.2014.12.007_bib0050","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/(SICI)1096-8628(19971031)72:3<253::AID-AJMG1>3.0.CO;2-S","article-title":"Multiple malformation syndrome following fluconazole use in pregnancy: report of an additional patient","volume":"72","author":"Aleck","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.reprotox.2014.12.007_bib0055","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.yrtph.2014.07.012","article-title":"Nonclinical safety assessment of efinaconazole solution (10%) for onychomycosis treatment","volume":"70","author":"Jo","year":"2014","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.reprotox.2014.12.007_bib0060","first-page":"1010","article-title":"Safety and pharmacokinetics of efinaconazole 10% solution in healthy volunteers and patients with severe onychomycosis: low systemic exposure suggests remote drug-drug interaction potential","volume":"12","author":"Jarratt","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.reprotox.2014.12.007_bib0065","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/tera.1420080311","article-title":"Skeletal deviations in rats: malformations or variations?","volume":"8","author":"Kimmel","year":"1973","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2014.12.007_bib0070","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/tera.1420460210","article-title":"Developmental stages of the CD (Sprague-Dawley) rat skeleton after maternal exposure to ethylene glycol","volume":"46","author":"Marr","year":"1992","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2014.12.007_bib0075","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jaad.2012.10.013","article-title":"Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies","volume":"68","author":"Elewski","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.reprotox.2014.12.007_bib0080","first-page":"186","article-title":"Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study","volume":"12","author":"Tschen","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.reprotox.2014.12.007_bib0085","first-page":"20","article-title":"Efinaconazole 10% solution: a new topical treatment for onychomycosis: contact sensitization and skin irritation potential","volume":"6","author":"Del Rosso","year":"2013","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.reprotox.2014.12.007_bib0090","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jasms.2004.04.036","article-title":"Quantitation of lanosterol and its major metabolite FF-MAS in an inhibition assay of CYP51 by azoles with atmospheric pressure photoionization based LC\u2013MS\/MS","volume":"15","author":"Trosken","year":"2004","journal-title":"J Am Soc Mass Spectrom"},{"key":"10.1016\/j.reprotox.2014.12.007_bib0095","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2605.2007.00838.x","article-title":"Endocrine-disrupting properties in vivo of widely used azole fungicides","volume":"31","author":"Taxvig","year":"2008","journal-title":"Int J Androl"},{"key":"10.1016\/j.reprotox.2014.12.007_bib0100","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1128\/AAC.02067-12","article-title":"Azole affinity of sterol 14alpha-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens","volume":"57","author":"Warrilow","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.reprotox.2014.12.007_bib0105","first-page":"22","article-title":"Postulated pathogenic pathway in triazole fungicide induced dysmorphogenic effects","author":"Menegola","year":"2006","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.reprotox.2014.12.007_bib0110","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1096\/fasebj.10.9.8801179","article-title":"Retinoids and Hox genes","volume":"10","author":"Marshall","year":"1996","journal-title":"FASEB J"},{"issue":"Suppl 1","key":"10.1016\/j.reprotox.2014.12.007_bib0115","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1439-0507.1989.tb02295.x","article-title":"Toxicological profile and safety evaluation of antifungal azole derivatives","volume":"32","author":"Van Cauteren","year":"1989","journal-title":"Mycoses"}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623814003189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623814003189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:38:13Z","timestamp":1760189893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623814003189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":23,"alternative-id":["S0890623814003189"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2014.12.007","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efinaconazole: Developmental and reproductive toxicity potential of a novel antifungal azole","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2014.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}